Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Numbify Sanitize

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredients
  • Lidocaine Hydrochloride 400 mg/10000 mg
  • Benzalkonium Chloride 13 mg/10000 mg
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2020
Label revision date
April 29, 2020
Drug Information (PDF)
Prescribing information, PDF file
Active ingredients
  • Lidocaine Hydrochloride 400 mg/10000 mg
  • Benzalkonium Chloride 13 mg/10000 mg
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2020
Label revision date
April 29, 2020
Manufacturer
Ridge Properties
Registration number
part348
NDC root
69804-087
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info (3 NDCs)
Packaging & NDC Codes (3)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that there is no specific drug name or relevant information provided in the bullet list. Without details about a particular medication, its uses, or how it works, I am unable to create a summary for you. If you have specific information about a drug, please share it, and I would be happy to help!

Uses

It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it should be used is not available.

Additionally, there are no details regarding any potential teratogenic effects (which are harmful effects on a developing fetus) or nonteratogenic effects (which do not affect fetal development). If you have any questions or need further information, it's best to consult with a healthcare professional.

Dosage and Administration

It seems that the specific dosage and administration information for the medication you are inquiring about is not available in the provided text. Typically, this information would include how much of the medication to take, how to take it (for example, orally or through an injection), and how often to take it.

To ensure you use the medication safely and effectively, it's important to refer to the official guidelines or consult with your healthcare provider. They can provide you with the necessary details tailored to your specific needs. Always follow their instructions closely for the best results.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, you can use this medication without concerns about these particular issues. However, always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for your individual health needs.

Side Effects

You may not experience any specific side effects from this medication, as there are no documented adverse reactions, warnings, or precautions associated with it. Clinical trials and postmarketing experiences have also not reported any side effects. If you have any concerns or unusual symptoms while taking this medication, it's always a good idea to consult your healthcare provider for guidance.

Warnings and Precautions

It seems that there are no specific warnings, precautions, or instructions provided in the information available. However, it's important to always be aware of potential side effects and to communicate openly with your healthcare provider about any concerns you may have regarding your medication.

If you experience any unusual symptoms or reactions while taking your medication, it’s crucial to stop using it and contact your doctor immediately. Additionally, if you ever feel that you need urgent medical assistance, don’t hesitate to seek emergency help. Regular check-ups and discussions with your healthcare provider can help ensure your safety and the effectiveness of your treatment.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

When it comes to using NUMBIFY SANITIZE (benzalkonium chloride spray) during pregnancy, there is currently no information available about its safety, recommended dosage, or any special precautions you should take. This means that if you are pregnant or planning to become pregnant, it’s important to consult with your healthcare provider before using this product. They can help you understand any potential risks and guide you on the best choices for your health and your baby's well-being. Always prioritize open communication with your doctor regarding any medications or products you consider using during pregnancy.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there are no statements about the product being excreted in breast milk or any associated risks for your infant. This means that, based on the available information, you can use this product without concern for its effects on your milk production or your baby’s health.

Pediatric Use

Currently, there is no specific information available regarding the use of this medication in children. This means that there are no recommended ages, dosage adjustments, or safety concerns outlined for pediatric patients (children). If you are considering this medication for a child, it is essential to consult with a healthcare professional to ensure it is appropriate and safe for their specific needs. Always prioritize your child's health and well-being by seeking expert advice.

Geriatric Use

While there is no specific information about the use of NUMBIFY SANITIZE (benzalkonium chloride spray) in older adults, it’s important to approach any new medication or treatment with caution. Since the drug insert does not mention dosage adjustments or safety concerns for elderly patients, you should consult with a healthcare professional before using this product. They can provide personalized advice based on your health needs and any other medications you may be taking. Always prioritize safety and ensure that any treatment is appropriate for your situation.

Renal Impairment

If you have kidney problems, it's important to know that you may need a lower dose of certain medications. Your healthcare provider will likely monitor your kidney function regularly through tests to ensure your safety. Additionally, adjustments to your medication dosage may be necessary based on your creatinine clearance levels, which measure how well your kidneys are filtering waste from your blood. Always communicate with your doctor about your kidney health to ensure the best treatment plan for you.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, so don't hesitate to ask questions or express any concerns you may have.

Drug Interactions

It's great to know that there are no known interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or new medications you start. Open communication helps prevent any potential issues and supports your overall well-being.

Storage and Handling

To ensure the best performance of your product, store it at room temperature and keep it away from direct light. It's important not to freeze the product, as this can affect its effectiveness. Once you open the product, be sure to discard any unused portion to maintain safety and quality. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What should I know about the storage of this product?

You should store it at room temperature, protect it from light, and avoid freezing. Discard the product after opening.

Are there any specific contraindications for this product?

No specific contraindications are listed for this product.

What precautions should I take if I have renal impairment?

If you have renal impairment, you may require a reduced dose and should monitor renal function tests regularly.

Is there any information regarding the use of this product during pregnancy?

There is no information provided regarding the use of this product during pregnancy.

Can nursing mothers use this product?

There are no specific warnings or recommendations regarding the use of this product in nursing mothers.

Is there any information about pediatric use?

No specific information regarding pediatric use or safety concerns for children is provided.

What about geriatric use of this product?

There is no specific information regarding geriatric use or dosage adjustments for elderly patients.

Packaging Info

Below are the non-prescription pack sizes of Numbify Sanitize (benzalkonium chloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Numbify Sanitize.
Details

Drug Information (PDF)

This file contains official product information for Numbify Sanitize, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The drug is identified by the SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the absence of these effects when evaluating treatment options for their patients.

Dosage and Administration

Healthcare professionals are advised to refer to the accompanying image for comprehensive dosage and administration details. The image contains essential information regarding the specific dosing ranges, administration routes, methods, and frequency of administration. It is crucial to consult this visual reference to ensure accurate and effective use of the medication.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

Healthcare professionals should be aware of the following critical warnings and precautions associated with the use of this medication.

In the event of any severe adverse reactions or unexpected symptoms, it is imperative to seek emergency medical assistance immediately. Healthcare providers should educate patients on recognizing signs that necessitate urgent care.

Patients are advised to discontinue use of the medication and contact their healthcare provider if they experience any concerning side effects or symptoms that may indicate a serious reaction. Prompt communication with a healthcare professional is essential to ensure patient safety and appropriate management.

Regular monitoring through laboratory tests may be necessary to assess the patient's response to the medication and to identify any potential complications. Healthcare professionals should determine the appropriate tests based on the individual patient's health status and the specific medication being prescribed.

It is crucial for healthcare providers to remain vigilant and proactive in monitoring their patients, ensuring that any necessary precautions are taken to mitigate risks associated with the medication.

Side Effects

There are no specific adverse reactions, warnings, or precautions associated with the use of this product as indicated in the available data. Clinical trials and postmarketing experiences have not reported any side effects. Therefore, healthcare professionals should be aware that the current information does not identify any adverse reactions related to this treatment.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Numbify Sanitize (benzalkonium chloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Numbify Sanitize.
Details

Pediatric Use

There is no specific pediatric use information, recommended ages, dosing differences, safety concerns, or special precautions for children provided in the prescribing information. Therefore, healthcare professionals should exercise caution when considering the use of this medication in pediatric patients, as the safety and efficacy in this population have not been established.

Geriatric Use

There is no specific information regarding the use of NUMBIFY SANITIZE (benzalkonium chloride spray) in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when administering this product to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable, given the lack of established guidelines for this population.

Pregnancy

There is no information available regarding the use of NUMBIFY SANITIZE (benzalkonium chloride spray) during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks and benefits before recommending this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may require a reduced dose of the medication. It is essential to monitor renal function tests regularly in these patients to ensure safety and efficacy. Adjustments in dosage may be necessary based on individual creatinine clearance levels to accommodate the altered pharmacokinetics associated with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management protocols and interventions tailored to the situation.

Documentation of the incident, including the substance involved, estimated dose, and time of ingestion, is crucial for effective management and treatment.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young individuals.

Storage and Handling

The product is supplied in packaging that includes specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from light exposure. Freezing the product is not permitted, as it may compromise its integrity. Additionally, once opened, the product must be discarded to maintain safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Numbify Sanitize, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Numbify Sanitize, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.